Company intelligence / Profile preview

Genpact

Ownership: Public · G
Employees: ~125000
Development stage: Other

Overview

Genpact delivers advanced technology services—including AI-driven analytics and automation—to accelerate drug/device development, regulatory compliance, supply chain resilience, patient engagement, and operational efficiency in the life sciences sector. It has been recognized as an industry leader by Everest Group and others for its impact on regulatory affairs and digital transformation in healthcare/life sciences. No clinical results as it does not run clinical trials.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Astellas PharmaThermo Fisher Scientific

Financials

Market cap: $5.9B
Total revenue: $1.3B
Enterprise value: $6.8B

Beyond the preview

Go deeper on Genpact.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genpact.

Explore the full profile